Latest 10-Q quarterly reports

Versigent PLC announced a 10% increase in net sales for the first six months of 2026, driven by volume growth and improved operational performance, alongside a significant increase in cash and cash equivalents.

Exagen Inc. announced a 15.9% increase in revenue for the second quarter of 2026, driven by higher test volumes and an expanded AVISE CTD platform, alongside improved gross margins.

Sterling Infrastructure, Inc. announced a significant increase in second-quarter revenue and profitability, largely fueled by its E-Infrastructure Solutions segment and strategic acquisitions.

Wisconsin Electric Power Company's Q2 2026 Form 10-Q filing reveals a significant increase in net income attributed to common shareholders, driven by rate adjustments and strategic capital investments.

Lemonade, Inc. has entered into a New Business Financing Agreement with Hannover Re (Ireland) DAC, securing up to $250 million for sales and marketing growth, while also reporting a 124% increase in net earned premium for the quarter.

Cipher Digital Inc. reported a significant net loss for Q2 2026, with revenues declining year-over-year, while expenses and debt increased substantially.

Nuvectis Pharma, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing clinical development, significant operating losses, and a substantial capital raise in July 2026.

Ichor Holdings announced a significant increase in net sales and improved gross margins for the second quarter of 2026, driven by robust demand in the semiconductor capital equipment industry.

WEC Energy Group announced a significant increase in net income for the second quarter of 2026, driven by robust performance in its Wisconsin segment and non-utility energy infrastructure operations.

Ameresco, Inc. announced its second quarter 2026 financial results, showing a 9.1% increase in revenue but a net loss attributable to common shareholders.

ADTRAN Holdings, Inc. announced a 6.1% year-over-year revenue increase for the second quarter of 2026, driven by strong demand in core markets and vendor consolidation, though the company still reported a net loss.

HNI Corporation's Q2 2026 filing shows a 121% revenue surge driven by the Steelcase acquisition, though net income declined significantly year-over-year for the six-month period.

Pinnacle West Capital Corporation and Arizona Public Service Company reported mixed financial results for the second quarter of 2026, with increased revenues offset by higher expenses.

Amalgamated Financial Corp. announced its second quarter 2026 financial results, showcasing significant growth in net interest income and total assets, alongside a notable increase in provisions for credit losses.

Harmony Biosciences announced robust Q2 2026 results, driven by significant net product revenue growth, strategic pipeline advancements, and effective cost management.

Katapult Holdings, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenue growth, a return to net income for the six-month period, but also highlighting significant going concern risks and the complexities of its pending mergers.

Centuri Holdings, Inc. announced a significant increase in revenue for the second quarter of 2026, driven by strong performance across its U.S. Gas and Canadian Operations segments, alongside strategic acquisitions.

Superior Group of Companies reported a 2.6% increase in net sales for Q2 2026, with net income rising significantly year-over-year, despite a notable trade name impairment charge.

Palvella Therapeutics reports substantial progress in its QTORIN rapamycin development for rare skin diseases, with an NDA submission on track for H2 2026 and a potential 2027 U.S. launch, alongside increased R&D spending.

Shoals Technologies Group reported a 47.4% revenue increase in Q2 2026, but net income and gross profit margin declined due to operational inefficiencies, product quality issues, and increased litigation expenses.

Global Business Travel Group, Inc. (GBTG) announced a substantial increase in Q2 2026 revenue and TTV, driven by acquisitions and transaction growth, while progressing towards its merger with Gaia Purchaser, Inc.

ImmunityBio, Inc. reported Q2 2026 results showing significant revenue growth but also substantial net losses and increased liabilities, alongside ongoing legal matters.

Faeth Therapeutics announced its Q2 2026 financial results, detailing a significant increase in operating expenses and net loss following the acquisition of Faeth Therapeutics and a concurrent private placement.

Hillman Solutions Corp. announced a 9.8% increase in net sales for Q2 2026, driven by acquisitions and core performance, while navigating rising costs and tariff uncertainties.

Dorman Products announced a significant increase in net sales and gross profit for the second quarter of 2026, largely driven by substantial tariff refunds and strategic pricing actions.

Thryv Holdings, Inc. announced its financial results for the second quarter of 2026, reporting a substantial decrease in revenue and a widening net loss compared to the prior year period.

Certara, Inc. announced its Q2 2026 financial results, reporting a net loss from continuing operations and completing the sale of its medical writing business.

Beam Therapeutics reports on advancements in its gene editing therapies for sickle cell disease and AATD, alongside a substantial net loss and ongoing need for capital.

Larimar Therapeutics reports progress on its nomlabofusp Biologics License Application submission and positive long-term safety data, while acknowledging substantial operating losses and the necessity for future capital raises.

RYTHM Inc. announced a significant increase in revenue and a shift to net income for the six months ended June 30, 2026, driven by substantial growth in licensing revenue and a notable non-cash tax benefit.